Funding · Company
Comanche Biopharma Corp.
Concord, MABiotech & Pharma
Comanche Biopharma Corp. of Concord, MA has disclosed $74M across 2 Form D offerings filed with the SEC between May 12, 2023 and Jan 17, 2024.
$74M
Total disclosed
2
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$38M
Form D · Jan 17, 2024 ↗
Q1 2024
· target $75M
Filing details
HeadquartersConcord, MAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2020SEC CIK0001873062Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →